SRS SYSTEM - Leading the gerd revolution
GERD is caused by abnormal regurgitation of fluids from the stomach into the esophagus.
The SRS™ innovative endoscopy system is for the treatment of Gastroesophageal Reflux Disease (GERD). Medigus’ endoscopic SRS system performs an anterior fundoplication in lieu of current surgical procedures, without opening the abdominal cavity.
The entire SRS system is CE marked and FDA cleared.
READ MORE
PATIENT INFO
A novel system (SRS™) enables a minimally invasive procedure that can provide long lasting relief and improved quality of life for people suffering from acid reflux.READ MORE
HEALTHCARE PROFESSIONAL
Medigus' SRS is a cutting edge disposable endoscope that provides you with simple and effective treatment for GERD symptoms in lieu of laparoscopic surgery.READ MORE
Medigus is a medical device company specializing in developing innovative endoscopic procedures and devices, including the revolutionary disposable endoscope for the treatment of GERD (Gastroesophageal Reflux Disease).
The company, which was founded in January 2000, is based in Israel and is publicly traded on the TASE. Medigus owns a unique and outstanding technological platform enabling the company to bring into the world state-of-the-art medical device products.
Read more
News
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
EAES European Association for Endoscopic Surgery
21-05-2013
June 19-22, 2013
Vienna, Austria
Visit us at booth #25
Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando
16-05-2013
Medigus Ltd. (MDGS.TA), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up da...
Read moreSuccessful five-year follow-up data from SRS™ pilot study
05-05-2013
Medigus (TASE:MDGS) announced today that it had received five-year follow-up results of a pilot study of its SRS™ endoscopic system for the treatment of Gastroesophageal Reflux Disease (GERD). The ...
Read moreSAGES Society of American Gastrointestinal and Endoscopic Surgeons
10-04-2013
April 17-20, 2013
Baltimore, Maryland
www.sages2013.org
Read more
Medigus Signed a Distribution Agreement in China
12-03-2013
Local distributor to purchase SRS™II systems for a minimum of $3.85 million.
Read moreMedigus completed $8M private placement by OrbiMed
04-03-2013
Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed ...
Read moreAGA Tech Summit: Fostering Innovation and Technology in Digestive and Metabolic Diseases
14-02-2013
March 15-16, 2013
East Palo Alto, California
www.gastro.org/...
Columbia Medical Center Offers SRS Procedures
13-02-2013
Medigus (TASE:MDGS) announces that Columbia University Medical Center, Department of Surgery (New-York, New-York), now offers the SRS™ procedure for transoral incisionless treatment of GERD.
Read moreMedigus announces an exclusive distribution agreement for the SRS™II in Turkey
16-01-2013
Medigus (TASE:MDGS) announces an exclusive distribution agreement for the SRS™II in Turkey.
Read more